On this episode of Psychedelic Insiders, Doug Drysdale, CEO of Cybin Inc. powers through a cold to share some insights on the present and future of psychedelic medicine. He talks to Microdose's Jason Najum about psychedelic drug development, mental health therapies involving psychedelics, and more.

PSYCHEDELIC INSIDERS

Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company.

LINKS:

Video of interview: https://youtu.be/7AfG58q-KGw

www.cybin.com

www.microdose.buzz

Subscribe today!

on Apple Podcasts: https://podcasts.apple.com/us/podcast/psychedelic-insiders/id1531628901

on Spotify: https://open.spotify.com/show/3Nyc58Ov7GYBeeLcWheBSx

on Youtube: https://www.youtube.com/playlist?list=PLMj79P4l-kSl5YY6VA9mbkOxQPDrM5NE1